---
layout: minimal-medicine
title: Clofarabine
---

# Clofarabine
### Generic Name
Clofarabine

### Usage
Clofarabine is primarily used to treat relapsed or refractory acute lymphoblastic leukemia (ALL) in children and young adults aged 1 to 21 years.  This means it's used when ALL has returned after treatment (relapsed) or hasn't responded to previous treatments (refractory).  It's often part of a combination therapy regimen, meaning it's used alongside other medications.  While the primary indication is for ALL, clofarabine is also used off-label in some cases of relapsed or refractory acute myeloid leukemia (AML), and refractory Langerhans cell histiocytosis.  Off-label use means the medication is used for a condition not explicitly approved by regulatory agencies, but based on clinical experience and evidence.  It's crucial to consult with a healthcare professional to determine if clofarabine is appropriate for a specific condition.


### Dosage
Dosage is highly individualized and depends on several factors, including the patient's age, weight, body surface area (BSA), and the specific medical condition being treated.  It's always calculated and administered by a healthcare professional.  Generally, clofarabine is administered intravenously (IV).

**For relapsed/refractory ALL (in children and young adults aged 1-21 years):** The typical dose is 52 mg/mÂ²/day given intravenously for 5 consecutive days. Cycles are repeated every 2-6 weeks, depending on the patient's response and recovery.

**Off-label uses (dosage varies significantly and depends on the specific regimen):**  For instance, in adults with relapsed/refractory ALL or AML, different dosing schedules might be used, sometimes in combination with other chemotherapeutic agents.  These dosages are determined on a case-by-case basis by the oncologist, considering the patient's overall health and response to treatment.  Pediatric off-label uses also exist with adjusted dosage based on weight or BSA.


### Side Effects
Clofarabine can cause various side effects, ranging from mild to severe. Common side effects include:

*   Headache
*   Fatigue
*   Nausea and vomiting
*   Diarrhea
*   Fever
*   Chills
*   Pain
*   Low blood cell counts (leukopenia, anemia, thrombocytopenia, neutropenia)
*   Increased liver enzyme levels
*   Increased creatinine levels (kidney function)
*   Rash
*   Hypotension (low blood pressure)

Less common but more serious side effects can include:

*   Capillary leak syndrome
*   Sepsis
*   Severe infections
*   Hepatic toxicity (liver damage)
*   Renal toxicity (kidney damage)
*   Hemorrhage
*   Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (rare, but potentially life-threatening skin reactions)


If you experience any concerning side effects, contact your healthcare provider immediately.

### How it Works
Clofarabine is a purine nucleoside analog.  It's converted in the body to clofarabine triphosphate, which interferes with DNA synthesis and repair within leukemia cells.  This inhibition of DNA replication and repair leads to cell death and ultimately helps to reduce the number of cancerous cells. The mechanism also involves disrupting the mitochondrial membrane within cancer cells, ultimately causing cell death.


### Precautions
*   **Hypersensitivity:** Clofarabine is contraindicated in patients with known hypersensitivity to clofarabine or any of its components.
*   **Hepatic and Renal Impairment:**  Patients with severe liver or kidney disease should not receive clofarabine, and those with moderate impairment may require dose adjustments.  Close monitoring of liver and kidney function is crucial during treatment.
*   **Bone Marrow Suppression:** Clofarabine can significantly suppress bone marrow function, leading to low blood cell counts. Regular blood tests are needed to monitor this.
*   **Tumor Lysis Syndrome:**  This condition occurs when large numbers of cancer cells are rapidly destroyed, releasing harmful substances into the bloodstream.  Preventive measures are often implemented to manage this risk.
*   **Infections:**  The risk of serious infections is increased due to bone marrow suppression.  
*   **Pregnancy and Breastfeeding:** Clofarabine is categorized as pregnancy category D, meaning it can cause harm to a developing fetus.  Effective contraception is essential for both men and women during treatment. Breastfeeding is not recommended during treatment and for at least two weeks afterward.
*   **Drug Interactions:** Clofarabine can interact with other medications;  it's vital to inform your healthcare provider of all medications, supplements, and herbal remedies being taken.


### FAQs
*   **Q: How is clofarabine administered?**  A: Clofarabine is typically given intravenously (IV) over a specific period, as determined by a healthcare professional.
*   **Q: How long will I be on clofarabine?**  A: The duration of treatment varies depending on individual response and the treatment plan developed by your doctor.
*   **Q: What should I do if I miss a dose?**  A: Do not attempt to adjust your dose yourself. Contact your healthcare provider immediately to discuss how to proceed.
*   **Q: How should clofarabine be stored?**  A:  Refer to the specific storage instructions provided with the medication.  Generally, medications should be stored according to the manufacturer's instructions.
*   **Q: Are there any long-term effects of clofarabine?** A:  Long-term effects are possible, and ongoing monitoring is essential. Your healthcare provider can discuss potential long-term effects and the importance of follow-up care.  
*   **Q:  What if I experience side effects?**  A: Contact your doctor or healthcare provider immediately to report any side effects, especially if they are severe or persistent.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with your healthcare provider before starting or stopping any medication, or if you have questions or concerns about your health or treatment.  The information provided here is based on publicly available data and may not encompass all possible details or the most up-to-date information.  Always refer to the official prescribing information from the manufacturer for the most accurate and complete information.
